Using a polymerase chain reaction-based amplification assay, we measur
ed telomerase activity in surgically resected pancreatic ductal carcin
omas (n = 16 cases) and normal ducts (n = 6), comparing findings with
the telomerase activity of a human pancreatic cancer cell line, MIA Pa
Ca-2, as a standard, i.e., relative telomerase activity was determined
. Telomerase activity was expressed as the equivalent telomerase inten
sity of the number of cells of MIA PaCa-2 per mu g protein of tissue s
amples. The median value for telomerase activity in normal pancreatic
ducts was 0.13 and the 25th and 75th percentile were 0.01 and 0.76. Th
e median value for telomerase activity in pancreatic ductal adenocarci
noma was 34.7 (25th percentile, 4.98; and 75th percentile, 296), signi
ficantly higher than that of normal ducts (P < 0.001). When the cut-of
f value was set at 1.0 and 3.0, the telomerase positivity rate of panc
reatic ductal adenocarcinomas was 100% and 81.3%, respectively. Telome
rase may be a specific marker for pancreatic ductal carcinomas.